STOCK TITAN

QT Imaging Holdings SEC Filings

QTIH OTC

Welcome to our dedicated page for QT Imaging Holdings SEC filings (Ticker: QTIH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

QT Imaging Holdings’ cutting-edge breast and musculoskeletal imaging technology may be radiation-free, but its SEC paperwork certainly isn’t. Clinical-trial updates, FDA clearance timelines, and multi-year R&D commitments are scattered across hundreds of pages—details that can determine the value of every share. If you’ve ever opened a 300-page 10-K and wondered where the pipeline milestones or cash-burn figures hide, you know the challenge.

Stock Titan’s AI solves that problem instantly. Our platform turns a dense QT Imaging Holdings quarterly earnings report 10-Q filing into plain-English insights, flags material events from each 8-K, and pushes QT Imaging Holdings Form 4 insider transactions real-time to your dashboard. Prefer narrative questions? Just ask “understanding QT Imaging Holdings SEC documents with AI” and you’ll see streamlined answers. The system covers every form—10-K, 10-Q, 8-K, S-1, and the all-important QT Imaging Holdings proxy statement executive compensation—with real-time EDGAR feeds and side-by-side historical comparisons.

Why it matters: Investors use these filings to gauge when FDA approvals may hit revenue, track capital raises, and spot QT Imaging Holdings insider trading Form 4 transactions ahead of clinical catalysts. Our AI-powered summaries highlight R&D trends, segment margins, and patent disclosures, offering the QT Imaging Holdings earnings report filing analysis you need without parsing footnotes. Whether you’re confirming an 8-K material events explained alert or diving into a QT Imaging Holdings annual report 10-K simplified, Stock Titan delivers the clarity professionals require—saving hours and surfacing insights that move portfolios.

Rhea-AI Summary

QT Imaging Holdings disclosed terms of subscription and pre-funded warrants issued in a private placement and related registration rights. The Subscription Warrants include standard adjustments for stock splits and similar events and provide that, in a Fundamental Transaction, holders may receive alternate consideration in the form and proportion offered to common stockholders. The company may, at a holder's option, purchase unexercised portions of Subscription Warrants for cash equal to the Black Scholes value; if the Fundamental Transaction is not within the company's control, holders receive the same form of consideration offered to common stockholders.

The Pre-Funded Warrants are exercisable for 5,424,083 shares of common stock at $0.0001 per share and expire upon full exercise. Under the Registration Rights Agreement entered with purchasers, the company must file a registration statement for resale of registrable securities within 30 days and have it declared effective as promptly as practicable, and in any event within 90 days (or 120 days if the SEC conducts a full review).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.93%
Tags
current report

FAQ

What is the current stock price of QT Imaging Holdings (QTIH)?

The current stock price of QT Imaging Holdings (QTIH) is $2.33 as of October 2, 2025.

What is the market cap of QT Imaging Holdings (QTIH)?

The market cap of QT Imaging Holdings (QTIH) is approximately 69.4M.
QT Imaging Holdings

OTC:QTIH

QTIH Rankings

QTIH Stock Data

69.37M
21.15M
26.42%
9.28%
0.97%
Medical Devices
Healthcare
Link
United States
Novato